Immunogenicity of a Third Dose of the BNT162b2 mRNA Covid-19 Vaccine in Patients with Impaired B Cell Reconstitution After Cellular Therapy—A Single Center Prospective Cohort Study - Concepedia

Concepedia

Publication | Open Access

Immunogenicity of a Third Dose of the BNT162b2 mRNA Covid-19 Vaccine in Patients with Impaired B Cell Reconstitution After Cellular Therapy—A Single Center Prospective Cohort Study

DOI Full Paper Access

14

Citations

10

References

2022

Year

Ron Ram, Tal Freund, Tami Halperin, Ronen Ben‐Ami, Odelia Amit, Yael Bar‐On, Ofrat Beyar‐Katz, Nili Eilaty, Ronit Gold, Sigi Kay,

Transplantation and Cellular Therapy

References

	Year	Citations

Page 1